Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goebeler

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
The British Journal of Dermatology|October 5, 2021
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trialM Goebeler, Z Bata-Csörgő, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2022
Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout GermanyR N Werner, A Pennitz, L Eisert, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
ESMO Open|May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upI Lugowska, J C Becker, P A Ascierto, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2023
Early clinical trial unit tumor board: a real-world experience in a national cancer networkL Weiss, K Dorman, M Boukovala, et al.
The British Journal of Dermatology|July 14, 2017
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysisT Schmidt, M Hoch, S S Lotfi Jad, et al.
Leukemia|August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study groupM A Hoechstetter, R Busch, B Eichhorst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 12, 2026
European S2k guidelines on management of autoimmune blistering diseases in children and adolescentsA Nanda, B Tedbirt, C Bodemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P Joly, B Horvath, Α Patsatsi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2022
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)L Borradori, N Van Beek, C Feliciani, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
The British Journal of Dermatology|October 5, 2021
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trialM Goebeler, Z Bata-Csörgő, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2022
Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout GermanyR N Werner, A Pennitz, L Eisert, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
ESMO Open|May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upI Lugowska, J C Becker, P A Ascierto, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2023
Early clinical trial unit tumor board: a real-world experience in a national cancer networkL Weiss, K Dorman, M Boukovala, et al.
The British Journal of Dermatology|July 14, 2017
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysisT Schmidt, M Hoch, S S Lotfi Jad, et al.
Leukemia|August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study groupM A Hoechstetter, R Busch, B Eichhorst, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 12, 2026
European S2k guidelines on management of autoimmune blistering diseases in children and adolescentsA Nanda, B Tedbirt, C Bodemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P Joly, B Horvath, Α Patsatsi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2022
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)L Borradori, N Van Beek, C Feliciani, et al.
Pageof 13